Kevin N. Heller - Mar 21, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Executive Vice President, Research and Development
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 06:04 PM
Previous filing
Oct 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +7.5K $0.00 7.5K Mar 21, 2022 Voting Common Stock 7.5K $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Remarks:

Executive Vice President, Research and Development